RXR β 1 Antibodies

Santa Cruz Biotechnology offers a broad range of RXR β 1 monoclonal antibodies for research focused on understanding this critical protein. RXR β 1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RXR β 1, or Retinoid X Receptor beta 1, is a member of the nuclear receptor superfamily and plays a vital role in regulating gene expression in response to retinoids and other ligands. RXR β 1 participates in numerous biological processes, including cell differentiation, development, and metabolism. Research involving RXR β 1 has significant implications for understanding cancer and metabolic disorders. Scientists worldwide utilize RXR β 1 monoclonal antibodies to explore cellular pathways and molecular mechanisms. Ongoing studies of RXR β 1 continue to reveal new insights about its potential as a therapeutic target. Santa CruzBiotechnology monoclonal antibodies enable researchers to advance scientific understanding of RXR β 1 and its role in human health and disease.